ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.340
-0.070 (-4.96%)
At close: Nov 13, 2026, 4:00 PM EST
1.331
-0.009 (-0.68%)
After-hours: Nov 13, 2026, 7:30 PM EST
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $188.49 million as of November 13, 2026. It is the 20,817th most valuable company in the world and the 3,565th biggest in the United States. Its market cap has decreased by 62.43% in one year.
Market Cap
188.49M
Enterprise Value
441.19M
1-Year Change
-62.43%
Global Rank
Country Rank
#3,565 United States
Category
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $188.49M, a decrease of -90.77%. That is a compound annual growth rate of -30.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 188.49M | -56.90% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 297.69M |
| BioAge Labs | 255.07M |
| Lifecore Biomedical | 243.36M |
| Canopy Growth | 240.43M |
| SIGA Technologies | 196.88M |
| Anika Therapeutics | 179.50M |
| Akebia Therapeutics | 131.67M |
| Journey Medical | 122.21M |